Latest News about CERE
Recent news which mentions CERE
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
From Benzinga
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
May 20, 2024
From Motley Fool
Tickers
CERE
From InvestorPlace
Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
April 18, 2024
From Benzinga
From Benzinga
From InvestorPlace
Is AbbVie Stock a Buy Now?
February 22, 2024
From Motley Fool
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
February 16, 2024
From Benzinga
UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst
February 06, 2024
From Benzinga
AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall
February 02, 2024
From Benzinga
AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures
January 29, 2024
From Benzinga
7 Dividend Aristocrats That Will Pay You for Years to Come
January 22, 2024
Tags
CERE
NYSE:ABBV,NASDAQ:IMGN,NASDAQ:CERE,NYSE:ALB,NYSE:MCD,NASDAQ:SBUX,NYSE:ATO,NYSE:NEE,NYSE:APD,NYSE:LEG
ABBV
From InvestorPlace
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
From Benzinga
Is AbbVie Stock a Buy Now?
January 07, 2024
From Motley Fool
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
From Benzinga
JP Morgan Maintains Neutral Rating for Cerevel Therapeutics Hldg: Here's What You Need To Know
December 28, 2023
Tickers
CERE
From Benzinga
Tesla To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Friday
December 22, 2023
From Benzinga
The 7 Most Undervalued Growth Stocks to Buy in December
December 13, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
December 11, 2023
From Benzinga
The 3 Best Cheap Stocks to Buy in December
December 10, 2023
From InvestorPlace
From Motley Fool
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
December 10, 2023
From Motley Fool
From Motley Fool
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
December 07, 2023
From Benzinga
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 07, 2023
From Benzinga
Why Cerevel Therapeutics Stock Is Higher
December 07, 2023
From Benzinga
Why Is Cyngn (CYN) Stock Up 73% Today?
December 07, 2023
From InvestorPlace
Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday
December 07, 2023
From Benzinga
LILM Stock Alert: Lilium Partners Up With Lufthansa
December 07, 2023
From InvestorPlace
Why Is Cerevel Therapeutics (CERE) Stock Up 12% Today?
December 07, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.